Recent Posts
- Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.
- ABA Intake Automation Found Its Market by Accident: Carelu Was Built to Qualify Sales Leads for Contractors, Then a Cold LinkedIn Message Pointed It Toward Autism Care.
- Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.
- IACC Adopts 2026-2028 Autism Strategic Plan With a $747.4 Million Funding Recommendation. NIH Named Profound Autism a Highlighted Funding Topic the Same Morning, and HRSA Filed 41 Corrections.
- Methamphetamine and Cocaine Now Drive a Third of Overdose Deaths, and There Is No Medication to Treat Them. The Stimulant Crisis Meets a Treatment System Built for Opioids.
Recent Comments
No comments to show.